DSA Introduces BioStand™ at LabAutomation 2004

San Jose, California, February 2004 --- Data Science Automation (DSA) announced its new BioStand product and development tool at the LabAutomation 2004 Conference and Exposition, sponsored by the Association for Laboratory Automation (ALA), in San Jose CA.

Based on National Instruments (Nasdaq: NATI) technologies, BioStand is designed for multi-vendor device integration and to connect 'islands of automation' in pharmaceutical/biotechnology laboratories for drug discovery, genomics, proteomics, and quality control.

It is a practical alternative to high-cost, single vendor solutions. It can be used to enhance the automation of just a single workcell, or to integrate simple, standard, and extended workcells already in the laboratory.

BioStand offers a comprehensive framework to build, schedule and optimize screening sequences for pharmaceutical and biotechnology applications. The interactive sequence wizard dynamically creates sequences, subsequences and process dependencies for assays that can be screened in both serial and parallel operation.

Researchers can specify instrument classes, instrument models, and process parameters based on BioStand modules for each specific laboratory devices in use.

About Data Science Automation
Data Science Automation, Inc. is an automation engineering firm specializing in developing highly technical PC-based solutions to demanding data acquisition, analysis, process, and quality control applications. With offices and certified training centers in Pittsburgh, Philadelphia and Cleveland, DSA is a National Instruments Select Integration Partner, Microsoft Certified Partner, and Registered Member in the Control and Information Systems Integrator Association. DSA won Pittsburgh Technology 50 Awards three out of the last five years and the Pittsburgh Business Times 100 twice.